<?xml version="1.0" encoding="UTF-8"?>
<ref id="B138-pharmaceutics-12-00171">
 <label>138.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Hu</surname>
    <given-names>C.-M.J.</given-names>
   </name>
   <name>
    <surname>Chen</surname>
    <given-names>Y.-T.</given-names>
   </name>
   <name>
    <surname>Fang</surname>
    <given-names>Z.-S.</given-names>
   </name>
   <name>
    <surname>Chang</surname>
    <given-names>W.-S.</given-names>
   </name>
   <name>
    <surname>Chen</surname>
    <given-names>H.-W.</given-names>
   </name>
  </person-group>
  <article-title>Antiviral efficacy of nanoparticulate vacuolar ATPase inhibitors against influenza virus infection</article-title>
  <source>IJN</source>
  <year>2018</year>
  <volume>13</volume>
  <fpage>8579</fpage>
  <lpage>8593</lpage>
  <pub-id pub-id-type="doi">10.2147/IJN.S185806</pub-id>
  <pub-id pub-id-type="pmid">30587980</pub-id>
 </element-citation>
</ref>
